---
title: "Zhejiang Huakang Pharmaceutical Co.,Ltd. (605077.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/605077.SH.md"
symbol: "605077.SH"
name: "Zhejiang Huakang Pharmaceutical Co.,Ltd."
industry: "Packaged Foods and Meats"
datetime: "2026-05-21T07:39:16.948Z"
locales:
  - [en](https://longbridge.com/en/quote/605077.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/605077.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/605077.SH.md)
---

# Zhejiang Huakang Pharmaceutical Co.,Ltd. (605077.SH)

## Company Overview

Zhejiang Huakang Pharmaceutical Co., Ltd. engages in the research, production, and sale of polyols and starch sugar worldwide. It offers polyols products such as xylitol, is a polyol that occurs naturally regular sugar raise blood sugar levels; sorbitol, is produced by the catalytic hydrogenation of D-glucose and is available as a free-flowing crystalline powder, and as aqueous solutions; maltitol a bulk sweetener produced from naturally occurring compounds in corn; erythritol, is produced by the enzymatic hydrolysis of starch into glucose, non-caloric, non-hygroscopic excipient with excellent sweet taste and cooling effect; lactitol is produced by hydrogenation of lactose; mannitol is derived from enzymatic hydrolysis of starch; isomalt is produced from sucrose as a raw material and transformed into isomaltulose by sucrose isomerase. In addition, the company offers starch sugar provide high fructose, glucose, maltose syrups, maltodextrin; as well as rare sugar d- xylose, and l-arabinose; and dietary fiber include polydextrose.

| Item | Detail |
|------|--------|
| Industry | Packaged Foods and Meats |
| Exchange | CN Market |
| Website | [www.huakangpharma.com](https://www.huakangpharma.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:13.000Z

**Overall: C (0.40)**

**Industry**: Packaged Foods and Meats

| Metric | Value |
|--------|-------|
| Industry Ranking | 75 / 136 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 52.47% |  |
| Net Profit YoY | -47.52% |  |
| P/B Ratio | 1.77 |  |
| Dividend Ratio | 1.12% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 5417192417.93 |  |
| Revenue | 4550257509.26 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 4.29% | C |
| Profit Margin | 3.10% | C |
| Gross Margin | 11.39% | E |
| Revenue YoY | 52.47% | A |
| Net Profit YoY | -47.52% | D |
| Total Assets YoY | 6.26% | C |
| Net Assets YoY | -1.65% | D |
| Cash Flow Margin | 302.97% | A |
| OCF YoY | 52.47% | A |
| Turnover | 0.58 | B |
| Gearing Ratio | 59.37% | D |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Zhejiang Huakang Pharmaceutical Co.,Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "52.47%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-47.52%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.77",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "1.12%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "5417192417.93",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "4550257509.26",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "4.29%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "3.10%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "11.39%",
          "rating": "E"
        },
        {
          "name": "Revenue YoY",
          "value": "52.47%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "-47.52%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "6.26%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "-1.65%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "302.97%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "52.47%",
          "rating": "A"
        },
        {
          "name": "Turnover",
          "value": "0.58",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "59.37%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 38.38 | 57/136 | 21.52 | 19.57 | 18.22 |
| PB | 1.77 | 39/136 | 1.83 | 1.68 | 1.56 |
| PS (TTM) | 1.19 | 38/136 | 1.72 | 1.40 | 1.25 |
| Dividend Yield | 1.12% | 66/136 | 4.56% | 3.94% | 2.79% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | HAI TIAN (603288.SH) | A | B | B | A | C | B |
| 02 | SHUANGHUI (000895.SZ) | B | C | A | C | C | B |
| 03 | HAID GROUP (002311.SZ) | B | C | A | C | B | B |
| 04 | YANGYUAN (603156.SH) | B | C | C | B | B | B |
| 05 | Wanchen Group (300972.SZ) | B | A | A | D | A | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-03-06T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 18.50 |
| Highest Target | 20.00 |
| Lowest Target | 20.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/605077.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/605077.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/605077.SH/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/605077.SH/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**